Showing results (441-450 of 858) with videos related to
Sort By:
Pageof 86
European Journal of Immunology|March 12, 2025
Differences in Phage Recognition and Immunogenicity Contribute to Divergent Human Immune Responses to Escherichia coli and Klebsiella pneumoniae PhagesHuu Thanh Le, Carola Venturini, Alicia Fajardo Lubian, et al.European Journal of Preventive Cardiology|February 24, 2026
Vascular Health After Quitting Smoking or Switching to E-Cigarette Use: A Systematic Review of Prospective Studies with GRADE AssessmentJacob George, Giusy Rita Maria La Rosa, Jacqueline Yu, et al.Plos One|September 19, 2008
Circulating apoptotic progenitor cells in patients with congestive heart failureDael Geft, Shmuel Schwartzenberg, Ori Rogowsky, et al.Diseases (Basel, Switzerland)|July 2, 2021
COVID-19-Associated Cardiovascular ComplicationsClement C E Lee, Kashan Ali, David Connell, et al.Spinal Cord|January 25, 2023
Orthotic walking outcome of persons with motor complete low thoracic spinal cord injury-a retrospective studyThangavelu Senthilvelkumar, Prashanth H Chalageri, Samuel Kirubakaran Durairaj, et al.Rheumatology International|August 16, 2008
Normal levels and function of endothelial progenitor cells in patients with psoriatic arthritisJacob N Ablin, Zacharinka Goldstein, Valerie Aloush, et al.The Journal of General Virology|July 24, 2014
Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agentsMahsa Shahidi, Enoch S E Tay, Scott A Read, et al.Plos One|August 28, 2015
Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon ResponseScott A Read, Enoch S Tay, Mahsa Shahidi, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|June 10, 2019
Molecular docking, spectroscopic studies on 4-[2-(Dipropylamino) ethyl]-1,3-dihydro-2H-indol-2-one and QSAR study of a group of dopamine agonists by density functional methodTintu K Kuruvilla, S Muthu, Johanan Christian Prasana, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 24, 2025
Dynamic Changes in Bilirubin Predict 90-Day Mortality in Patients With Hepatocellular Carcinoma and Acute Decompensations of Cirrhosis: The HCC-AD ScoreOliver Moore, Fran Neveu-Coble, Scott Read, et al.Pageof 86